Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

BACKGROUND: Neutropenia is a common toxicity in patients receiving myelosuppressive chemotherapy. In this prospective pilot study, we compared the efficacy and safety profiles of pegfilgrastim administered subcutaneously once per cycle and lenograstim administered subcutaneously daily six times per...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rossi, Luigi, Tomao, Federica, Lo Russo, Giuseppe, Papa, Anselmo, Zoratto, Federica, Marzano, Raffaella, Basso, Enrico, Giordani, Erika, Verrico, Monica, Ricci, Fabio, Pasciuti, Giulia, Francini, Edoardo, Tomao, Silverio
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2013
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832460/
https://ncbi.nlm.nih.gov/pubmed/24255599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S48387
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares